Skip Navigation

A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan GMI-1271 in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03701308

Study #:
STUDY00144208

Start Date:
Sep 22, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03701308

View Complete Trial Details & Eligibility at ClinicalTrials.gov